Effect of diabetes self-management education in type 2 diabetes management - a systematic umbrella review of meta-analysis

糖尿病自我管理教育对2型糖尿病管理的影响——一项系统性综述和荟萃分析

阅读:2

Abstract

BACKGROUND: Type 2 diabetes is a chronic metabolic health condition that affects millions of people worldwide. Diabetes self-management education (DSME) is an effective intervention approach and the potential to enhance the health status of diabetic patients and mitigate complications to the greatest possible extent. However, no systematic synthesis or comprehensive report has been conducted to date on the impact of DSME in patients with diabetes. This review aimed to identify existing evidence on DSME care for diabetes management and the extent to which interventions are included in the evidence base. METHODS: PubMed, EMBASE, Web of Science, and Cochrane library databases were searched from inception to the December 31, 2025. Systematic reviews with meta-analyses of randomized controlled trials were included, reporting an effect size to calculate the association between DSME and the outcomes related to HbA1c. Quality of each review was appraised using a Measurement Tool to Assess Systematic Reviews (AMSTAR). RESULTS: A total of 12 meta-analyses were included. In this study, we suggested that DSME will leads to a decrease in HbA1c (effect size [ES] = − 0.34%, 95% confidence interval [CI]: − 0.43% to − 0.25%). The associations of self-management intervention (ES = − 0.35%, 95%CI: − 0.50% to − 0.20%) and technology-based intervention (ES = − 0.33%, 95%CI: − 0.46% to − 0.20%) with lower HbA1c levels were observrd. Overall quality of the included reviews was high or moderate. CONCLUSIONS: This umbrella review consolidates the existing evidence demonstrating that DSME has a significant positive impact on HbA1c levels, among individuals with type 2 diabetes. Future research should prioritize the development and implementation of integrated DSME models to enhance their effectiveness across various health outcomes and ensure adaptability to diverse population needs. CLINICAL TRIAL NUMBER: Not applicable. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12902-026-02183-4.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。